Brandon Eilertson
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Tuberculosis Research and Epidemiology 3
- Antifungal resistance and susceptibility 1
- Co-authors
- David H. Canaday (2 shared papers)Timothy R. Sterling (3 shared papers)Miguel F. Herrera (2 shared papers)Amondrea Blackman (3 shared papers)Fernanda Maruri (3 shared papers)Liang Chen (5 shared papers)David C. Samuels (1 shared paper)W. Henry Boom (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Open Forum Infectious Diseases (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)Infection and Immunity (1 paper)
- Partner nations
- United StatesColombiaAustralia
In The Last Decade
Brandon Eilertson
13 papers receiving 498 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 265
- Applied Microbiology and Biotechnology 49
- Endocrinology 44
- Infectious Diseases 131
- Clinical Biochemistry 38
Countries citing papers authored by Brandon Eilertson
This map shows the geographic impact of Brandon Eilertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Eilertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Eilertson more than expected).
Fields of papers citing papers by Brandon Eilertson
This network shows the impact of papers produced by Brandon Eilertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Eilertson. The network helps show where Brandon Eilertson may publish in the future.
Co-authors
The 25 scholars most cited alongside Brandon Eilertson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 222 | |
| 2 | 2023 | 61 | |
| 3 | 2014 | 52 | |
| 4 | 2019 | 45 | |
| 5 | 2003 | 40 | |
| 6 | 2005 | 24 | |
| 7 | 2017 | 17 | |
| 8 | 2018 | 15 | |
| 9 | 2016 | 13 | |
| 10 | 2017 | 7 | |
| 11 | 2018 | 5 | |
| 12 | 2019 | 1 | |
| 13 | 2012 | 1 |
About Brandon Eilertson
Brandon Eilertson is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Molecular Biology and Endocrinology, having authored 13 papers that have together received 503 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Tuberculosis Research and Epidemiology (3 papers), Mycobacterium research and diagnosis (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Adolescent and Pediatric Healthcare (1 paper), Antibiotic Use and Resistance (1 paper), Antifungal resistance and susceptibility (1 paper) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Molecular Medicine (265 citations), Applied Microbiology and Biotechnology (49 citations), Endocrinology (44 citations), Infectious Diseases (131 citations) and Clinical Biochemistry (38 citations). Brandon Eilertson has collaborated with scholars based in United States, Colombia and Australia. Frequent co-authors include David H. Canaday, Timothy R. Sterling, Miguel F. Herrera, Amondrea Blackman, Fernanda Maruri, Liang Chen, David C. Samuels, W. Henry Boom, Ethan G. Leonard and Adam J. Gehring. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.